1. An explanation of the method of diagnosis used, including the results of any tests
or evaluations.
2. Information on alternative modes of treatment, as provided in s. 448.30, stats.,
which provides as follows:
"448.30 Information on alternate modes of treatment. Any physician who
treats a patient shall inform the patient about the availability of all alternate, viable
medical modes of treatment and about the benefits and risks of these treatments. The
physician's duty to inform the patient under this section does not require disclosure of:
(1) Information beyond what a reasonably well-qualified physician in a similar
medical classification would know.
(2) Detailed technical information that in all probability a patient would not
understand.
(3) Risks apparent or known to the patient.
(4) Extremely remote possibilities that might falsely or detrimentally alarm the
patient.
(5) Information in emergencies where failure to provide treatment would be more
harmful to the patient than treatment.
(6) Information in cases where the patient is incapable of consenting.".
3. A printed copy of the informational materials pertaining to the assessment and
treatment of ADHD prepared by the department of health and family services (DHFS).
The requirement for DHFS to prepare those materials is described below.
Treatment of ADHD With a Schedule II Controlled Substance
In addition to providing the materials described above, a physician who diagnoses
a child with ADHD and prescribes a Schedule II controlled substance for treatment of the
disorder must provide a printed copy of any materials pertaining to the substance which
have been prepared by DHFS.
A physician who is required to provide any of the information (as described above)
must obtain certification in writing from the parent or guardian of the child or the adult
to whom the information is provided, if any, that the physician has provided all of the
required information.
Penalty for Failure to Provide Information; Exemption
Under current law, a physician who, after investigation and a hearing, is found
guilty of unprofessional conduct is subject to disciplinary action by the medical examining
board. The bill provides that an allegation that a physician has failed to provide the
required information or obtain the required certification is an allegation of
unprofessional conduct. However, the bill provides that it is not unprofessional conduct
for a physician to fail to provide the informational materials prepared by DHFS, if the
physician made a reasonably diligent effort to obtain the materials from DHFS and
DHFS did not make materials available at the time the physician was required to provide
them.
PREPARATION OF INFORMATIONAL MATERIALS BY DHFS
Materials Pertaining to the Assessment and Treatment of ADHD

The bill requires DHFS to prepare informational materials on the assessment and
treatment of ADHD. These are the materials which must be provided by a physician who
prescribes any prescription drug for the treatment of ADHD in a child. The materials
must contain the following:
1. A summary of the practice parameters for the assessment and treatment of
children and adolescents with ADHD published by the American Academy of Child and
Adolescent Psychiatry.
2. A statement that a parent or guardian may seek treatment other than
prescription drugs for a child with ADHD.
Materials Pertaining to Schedule II Controlled Substances
In addition to the materials above, the bill requires DHFS to prepare informational
materials on certain Schedule II controlled substances. These are the additional
materials that must be provided by a physician who prescribes any Schedule II controlled
substance for treatment of ADHD in a child. DHFS must, in consultation with the State
Medical Society of Wisconsin, determine which Schedule II controlled substances are
routinely prescribed by physicians in this state to treat ADHD in children. For each of
these substances, DHFS must prepare materials containing the following information:
1. A statement that the substance is a Schedule II controlled substance under s.
961.16.
2. A summary of information included in the labeling of the substance required by
federal law pertaining to the safety and effectiveness of the substance when used to treat
ADHD in children, including any information relating to the potential for abuse or
development of dependence upon the drug.
3. A statement that use of a the Schedule II controlled substance to treat ADHD
may affect a person's eligibility to serve in the U.S. armed forces, if the DHFS so finds.
4. A statement that the use of a Schedule II controlled substance to treat ADHD
may affect the cost of a person's health insurance.
DHFS must prepare all of the informational materials within approximately 5
months after the effective date of the bill. Physicians are first required to provide the
required information beginning approximately 9 months after the effective date of the
bill.
Dissemination of Materials by the Department of Public Instruction
The bill requires the department of public instruction (DPI) to disseminate the
informational materials prepared by DHFS to appropriate public school staff.
AB672, s. 1 1Section 1. 115.357 of the statutes is created to read:
AB672,3,6 2115.357 Information on attention deficit hyperactivity disorder. The
3department shall disseminate to appropriate public school staff the information
4regarding the diagnosis and treatment of attention deficit hyperactivity disorder and
5prescription drugs used to treat the disorder prepared by the department of health
6and family services under s. 448.35 (2).
Note: Requires the DPI to distribute the informational materials prepared by
DHFS to appropriate public school staff.
AB672, s. 2 7Section 2. 448.02 (3) (a) of the statutes is amended to read:
AB672,4,19
1448.02 (3) (a) The board shall investigate allegations of unprofessional conduct
2and negligence in treatment by persons holding a license, certificate or limited
3permit granted by the board. An allegation that a physician has violated s. 253.10
4(3), 448.30, 448.35 (3), or 450.13 (2) or has failed to mail or present a medical
5certification required under s. 69.18 (2) within 21 days after the pronouncement of
6death of the person who is the subject of the required certificate or that a physician
7has failed at least 6 times within a 6-month period to mail or present a medical
8certificate required under s. 69.18 (2) within 6 days after the pronouncement of death
9of the person who is the subject of the required certificate is an allegation of
10unprofessional conduct. Information contained in reports filed with the board under
11s. 49.45 (2) (a) 12r., 50.36 (3) (b), 609.17 or 632.715, or under 42 CFR 1001.2005, shall
12be investigated by the board. Information contained in a report filed with the board
13under s. 655.045 (1), as created by 1985 Wisconsin Act 29, which is not a finding of
14negligence or in a report filed with the board under s. 50.36 (3) (c) may, within the
15discretion of the board, be used as the basis of an investigation of a person named in
16the report. The board may require a person holding a license, certificate or limited
17permit to undergo and may consider the results of one or more physical, mental or
18professional competency examinations if the board believes that the results of any
19such examinations may be useful to the board in conducting its investigation.
Note: Amends the statute which authorizes the medical examining board to
investigate allegations of unprofessional conduct and impose penalties against a
physician who is found guilty of unprofessional conduct. Specifically, provides that an
allegation that a physician violated s. 448.35 (3), stats., requiring physicians to provide
certain informational materials, as created in Section 3 of the bill, is an allegation of
unprofessional conduct. Section 3 of the bill also creates an exemption which provides
that a physician is not guilty of unprofessional conduct for failure to provide the
informational materials prepared by DHFS if the physician made a reasonably diligent
effort to obtain the materials from DHFS and DHFS did not make the materials available.
AB672, s. 3 20Section 3. 448.35 of the statutes is created to read:
AB672,5,2
1448.35 Attention deficit hyperactivity disorder. (1) Definitions. In this
2section:
AB672,5,33 (a) "Child" means a person under 18 years of age.
AB672,5,44 (b) "Department" means the department of health and family services.
AB672,5,55 (c) "Prescription drug" has the meaning given in s. 450.01 (20).
AB672,5,66 (d) "Prescription order" has the meaning given in s. 450.01 (21).
AB672,5,87 (e) "Schedule II controlled substance" means any substance included under s.
8961.16.
AB672,5,10 9(2) Informational materials. (a) The department shall prepare informational
10materials which contain the following:
AB672,5,1311 1. A summary of the practice parameters for the assessment and treatment of
12children and adolescents with attention deficit hyperactivity disorder published by
13the American Academy of Child and Adolescent Psychiatry.
AB672,5,1514 2. A statement that a parent or guardian may seek treatment other than
15prescription drugs for a child with attention deficit hyperactivity disorder.
AB672,5,2016 (b) The department shall, in consultation with the State Medical Society of
17Wisconsin, determine which Schedule II controlled substances are commonly
18prescribed by physicians in this state to treat attention deficit hyperactivity disorder
19and shall prepare informational materials pertaining to each of those substances
20containing the following information:
AB672,5,2121 1. A statement that the substance is a Schedule II controlled substance.
AB672,5,2522 2. A summary of the information included in the labeling of the substance
23under 21 USC 352 (f) which relates to the safety and effectiveness of the substance
24when used to treat attention deficit hyperactivity disorder in children and the
25potential for abuse or development of dependence upon the substance.
AB672,6,3
13. A statement that use of the substance to treat attention deficit hyperactivity
2disorder may affect a person's eligibility to serve in the U.S. armed forces, if the
3department so finds.
AB672,6,54 4. A statement that a person's use of the substance to treat attention deficit
5hyperactivity disorder may affect the cost of health insurance for that person.
AB672,6,96 (c) The materials prepared under pars. (a) and (b) shall be made available to
7physicians and to the public on the department's internet site. Upon the request of
8a physician, the materials under pars. (a) and (b) shall be provided to the physician
9in printed form.
AB672,6,1210 (d) The materials under pars. (a) and (b) shall be made available to physicians
11and to the public no later than the first day of the 6th month beginning after the
12effective date of this paragraph .... [revisor inserts date].
AB672,6,1513 (e) The department shall periodically review the materials under pars. (a) and
14(b) and shall exercise reasonable diligence in providing materials that are accurate
15and current.
AB672,6,19 16(3) Requirements for physicians. (a) Except in an emergency and as provided
17under par. (e), a physician who diagnoses a child with attention deficit hyperactivity
18disorder and issues a prescription order for treatment of the disorder shall provide
19the following information to the persons specified in par. (c):
AB672,6,2120 1. An explanation of the method of diagnosis used, including the results of any
21tests or evaluations.
AB672,6,2222 2. Information on alternative modes of treatment, as provided in s. 448.30.
AB672,6,2323 3. A printed copy of the materials prepared under sub. (2) (a).
AB672,7,424 (b) In addition to the information required under par. (a), except in an
25emergency and as provided under par. (e), a physician who diagnoses a child with

1attention deficit hyperactivity disorder and issues a prescription order for a Schedule
2II controlled substance for treatment of the disorder shall provide a printed copy of
3any materials pertaining to the prescribed substance which have been prepared by
4the department under sub. (2) (b) to the persons specified in par. (c).
AB672,7,115 (c) A physician required to provide information under this section shall provide
6the information to the parent or guardian of the child if the parent or guardian of the
7child is present when the prescription order is issued. If the child is 14 years of age
8or older, the physician shall also provide the information to the child. If the child's
9parent or guardian is not present at the time the prescription order is issued, the
10physician shall provide the information to an adult who is with the child at the time
11the prescription order is issued, if any.
AB672,7,1412 (d) A physician shall obtain from the parent or guardian of the child, or the
13adult to whom the information is provided, if any, certification in writing that the
14physician has provided the information required under this section.
AB672,7,2115 (e) A physician who treats a child for attention deficit hyperactivity disorder
16on a long-term basis with the same prescription drug shall provide the information
17and obtain the certification required under this section when issuing the initial
18prescription order for that prescription drug and at least once every 2 years
19thereafter. A physician is not required to provide the information described under
20sub. (2) if the physician reasonably believes that another physician has issued a
21prescription order for the child for the same prescription drug within the past year.
AB672,8,2 22(4) Exemption. It is not unprofessional conduct under s. 448.02 (3) (a) for a
23physician to fail to provide the materials required under this section if the physician
24made a reasonably diligent effort to obtain the materials from the department and

1the department did not make the materials available at the time that the physician
2was required to provide them.
Note: Creates the requirements for physicians to provide certain information
when issuing a prescription order to treat ADHD in a child, and for DHFS to prepare
those informational materials, as described above in the prefatory note.
Also creates an exemption to an allegation of unprofessional conduct as described
in the note following Section 2.
AB672, s. 4 3Section 4. Initial applicability.
AB672,8,64 (1) The treatment of sections 448.02 (3) (a) and 448.35 (3) of the statutes first
5applies to prescription orders that are issued on the first day of the 10th month
6beginning after the effective date of this subsection.
Note: Provides that the requirements pertaining to physicians do not take effect
until the first day of the 10th month after the effective date of the bill.
AB672,8,77 (End)
Loading...
Loading...